Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study)

Vickie McDonalda Department of Haematology, The Royal London Hospital, Barts Health NHS Trust, London, UKCorrespondence[email protected]
View further author information

Adrian Newlandb Academic Haematology Unit, Blizard Institute, Barts, London, UK;c The London School of Medicine & Dentistry, Queen Mary Institute of London, London, UKView further author information

Mervyn Morgand ITP Support Association, Bedfordshire, UKView further author information

Koo Wilsone Swedish Orphan Biovitrum AB, Stockholm, SwedenView further author information

Jameel Nazire Swedish Orphan Biovitrum AB, Stockholm, SwedenView further author information

Peter Maguiref Wickenstones Ltd, Oxfordshire, UKView further author information

Emma Geldmanf Wickenstones Ltd, Oxfordshire, UKView further author information

Tammy Wynnef Wickenstones Ltd, Oxfordshire, UKView further author information

show all

Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study)

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study)

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date